3eo9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3eo9" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3eo9.png|left|200px]] | [[Image:3eo9.png|left|200px]] | ||
{{STRUCTURE_3eo9| PDB=3eo9 | SCENE= }} | {{STRUCTURE_3eo9| PDB=3eo9 | SCENE= }} | ||
===Crystal structure the Fab fragment of Efalizumab=== | ===Crystal structure the Fab fragment of Efalizumab=== | ||
{{ABSTRACT_PUBMED_19258452}} | {{ABSTRACT_PUBMED_19258452}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Monoclonal Antibody]] | *[[Monoclonal Antibody|Monoclonal Antibody]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019258452</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Ding, J.]] | [[Category: Ding, J.]] | ||
Revision as of 07:48, 26 July 2012
Crystal structure the Fab fragment of Efalizumab
Template:ABSTRACT PUBMED 19258452
About this Structure
3eo9 is a 2 chain structure of Monoclonal Antibody with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J. Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4349-54. Epub 2009 Mar 3. PMID:19258452